Bon Natural Life Ltd
corporate_fare Company Profile
Bon Natural Life Ltd (NASDAQ:BON) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for BON at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-23, rated 8/10. Across its 4 most recent items scored 7 or higher, the top rating is 8/10, with 2 rated 8 or above. Recent SEC coverage for BON spans 6-K.
Recent high-impact activity:
- Bon Natural Life Swings to $9.2M Net Loss on Credit Losses and Supplier Impairments
- Bon Natural Life Forms Strategic Alliance with Tigerbone Group for New Health Initiatives
- Bon Natural Life Appoints Controller's Wife as CTO for $1,000/Month Salary
- Bon Natural Life Forms Strategic Partnership for AI-Driven Biomanufacturing Lab
Financial Snapshot
Short Interest & Short Volume
1.65 days to coverFINRA reported short interest of 8,727 shares in BON as of the September 15, 2026 settlement, a 46.7% decrease from the prior period — about 1.6 days to cover at its recent average daily volume. On October 2, 2026, 74.2% of BON volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
BON files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.